You're right, Nancy. Except for three thoughts that come to mind.
1 -- If people can't afford the pills, then they wouldn't have bought at the beginning and then stopped. They just wouldn't have bought. If sales dramatically went down from the first month, it could be because the drug wasn't good enough to buy a second time.
2 -- Vasomax was available at a big sale price in Mexico, so it was a lot cheaper there than Viagra, for example. If Viagra is selling there, then people are finding the money in Mexico for Viagra, at a higher price than Vasomax. So, money alone wouldn't be the issue for any dramatic decrease in Vasomax sales in Mexico.
3 -- People will go to Mexico to buy drugs from other countries, when the drug isn't approved in their country. For example, people in the US buy drugs in Mexico for that reason and for other reasons. So Mexico has been a traditional resource for more countries than itself. There were news items about Japanese buying Viagra in Mexico and of course we've had reports in this thread about US people buying Vasomax there. As long as Vasomax isn't approved in the US, many people who want it will secure it in Mexico. For that reason, I would expect that poor Mexico sales might indicate poor US sales when it's approved here. And that poor Mexico sales isn't simply indicative of an impoverished local population.
Linda |
